PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2
Journal of Virology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 13, 2025
ABSTRACT
Type
I
interferons
exert
their
antiviral
effects
against
SARS-CoV-2
by
inducing
the
expression
of
interferon-stimulated
genes
(ISGs),
including
but
not
limited
to
LY6E,
CH25H,
IFITM2/3,
and
IFIH1.
However,
effect
underlying
mechanisms
action
most
ISGs
in
infection
are
yet
fully
understood.
By
screening
109
ISG-knockout
cell
lines,
we
identify
that
phospholipid
scramblase
1
(PLSCR1),
an
interferon-inducible
protein,
acts
as
a
crucial
restriction
factor
infection.
Cells
lacking
PLSCR1
highly
susceptible
Conversely,
overexpression
inhibits
Depletion
enhances
cellular
entry
both
pseudotyped
authentic
SARS-CoV-2.
Mechanistically,
specifically
downregulating
plasma
membrane
ACE2,
virus’s
receptor,
without
affecting
overall
levels
ACE2
within
cell.
As
such,
unraveled
previously
unappreciated
which
exerts
its
restrictive
on
These
data
provide
new
insights
into
interplay
between
host
innate
immunity
shed
light
novel
therapeutics.
IMPORTANCE
Phospholipid
(PLSCR1)
has
been
identified
critical
In
this
study,
demonstrated
inhibited
primary
receptor
for
viral
entry.
Our
findings
elucidate
host-pathogen
interaction
only
deepens
our
understanding
immune
response
offers
potential
strategies
therapeutic
interventions
COVID-19.
Язык: Английский
Alternative Splicing as a Modulator of the Interferon-Gamma Pathway
Cancers,
Год журнала:
2025,
Номер
17(4), С. 594 - 594
Опубликована: Фев. 10, 2025
Interferon-gamma
(IFN-γ)
is
a
critical
cytokine
that
plays
pivotal
role
in
immune
system
regulation.
It
key
mediator
of
both
cellular
defense
mechanisms
and
antitumor
immunity.
As
the
sole
member
type
II
interferon
family,
IFN-γ
modulates
responses
by
activating
macrophages,
enhancing
natural
killer
cell
function,
regulating
gene
expression
across
multiple
processes.
Alternative
splicing
post-transcriptional
regulatory
mechanism
generates
mature
messenger
RNAs
from
single
gene,
dramatically
increasing
proteome
diversity
without
need
proportional
genome
expansion.
This
process
occurs
90–95%
human
genes,
with
alternative
events
allowing
for
production
diverse
protein
isoforms
can
have
distinct—or
even
opposing—functional
properties.
crucial
cancer
immunology,
potentially
generating
tumor
neoepitopes
modulating
responses.
However,
how
affects
IFN-γ’s
activity
still
poorly
understood.
review
explores
regulates
function
upstream
regulators
downstream
effectors
IFN-γ,
revealing
complex
response
modulation.
Key
transcription
factors
signaling
molecules
pathway
are
alternatively
spliced,
alter
signaling,
to
environmental
cues.
Specific
splice
variants
enhance
or
inhibit
IFN-γ-mediated
responses,
influencing
immunotherapy,
autoimmune
conditions,
infectious
disease
outcomes.
The
emerging
understanding
these
offers
promising
therapeutic
strategies
manipulating
through
targeted
molecular
interventions.
Язык: Английский
CRISPR-Cas: a game-changer in vaccine development and the fight against viral infections
Trends in Microbiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
Язык: Английский
Phospholipid scramblase 1: a frontline defense against viral infections
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2025,
Номер
15
Опубликована: Апрель 3, 2025
Phospholipid
scramblase
1
(PLSCR1)
is
the
most
studied
member
of
phospholipid
protein
family.
Its
main
function
to
catalyze
calcium
(Ca
2+
)-dependent,
ATP-independent,
bidirectional
and
non-specific
translocation
phospholipids
between
inner
outer
leaflets
plasma
membrane.
Additionally,
PLSCR1
identified
as
an
interferon-stimulated
gene
(ISG)
with
antiviral
activities,
its
expression
can
be
highly
induced
by
all
types
interferons
in
various
viral
infections.
Indeed,
numerous
studies
have
reported
direct
activities
through
interrupting
replication
processes
a
variety
viruses,
including
entry
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
nuclear
localization
influenza
A
virus
(IAV),
transactivation
human
immunodeficiency
(HIV),
Epstein-Barr
(EBV),
T-cell
leukemia
type-1
(HTLV1),
cytomegalovirus
(HCMV)
hepatitis
B
(HBV).
In
addition
these
also
regulates
endogenous
immune
components
defend
against
viruses
both
nonimmune
cells.
Such
include
potentiation
ISG
transcription,
activation
JAK/STAT
pathway,
upregulation
type
3
interferon
receptor
(IFN-λR1)
recruitment
Toll-like
9
(TLR9).
This
review
aims
summarize
current
understanding
PLSCR1’s
multiple
roles
frontline
defense
Язык: Английский
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li,
Paul Rothhaar,
Arthur Lang
и другие.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 22, 2025
Background
and
aims
The
contribution
of
innate
immunity
to
clearance
viral
infections
the
liver,
in
particular
sensing
via
Toll-like
receptor
3
(TLR3),
is
incompletely
understood.
We
aimed
identify
factors
contributing
TLR3
response
hepatocytes
CRISPR/Cas9
screening.
Methods
A
genome-wide
screen
on
pathway
was
performed
two
liver-derived
cell
lines,
followed
by
siRNA
knockdown
validation.
SiRNA
indisulam
treatment
were
used
study
role
RNA-binding
motif
protein
39
(RBM39)
upon
poly(I:C)
or
cytokine
infections.
Transcriptome,
proteome,
alternative
splicing
studied
RNA
sequencing
mass
spectrometry
depletion
RBM39.
Results
Our
identified
RBM39,
which
highly
expressed
hepatocytes,
as
an
important
regulator
pathway.
Knockdown
RBM39
with
indisulam,
aryl
sulfonamide
drug
targeting
for
proteasomal
degradation,
strongly
reduced
induction
interferon-stimulated
genes
(ISGs)
double-stranded
(dsRNA)
(seq)
that
transcription
and/or
key
components
IRF3,
RIG-I,
MDA5
affected
depletion,
along
multiple
other
cellular
processes
previously.
further
restrained
type
I
III
IFN
pathways
reducing
expression
individual
subunits
STAT1/2.
function
furthermore
not
restricted
hepatocytes.
Conclusion
a
regulatory
factor
intrinsic
immune
signaling.
Depletion
impaired
TLR3,
RIG-I/MDA5,
responses
affecting
basal
components.
Язык: Английский
Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes
Journal of Virology,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 25, 2025
ABSTRACT
Despite
the
diminishing
global
impact
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
virus
continues
to
circulate
and
undergo
mutations,
posing
ongoing
challenges
for
public
health.
A
comprehensive
understanding
entry
mechanisms
is
crucial
managing
new
epidemic
strains.
However,
cellular
processes
post-endocytosis
remain
largely
unexplored.
This
study
employs
proximity
labeling
examine
proteins
near
ACE2
post-viral
infection
identified
syntaxin-6
(STX6)
as
a
factor
that
inhibits
SARS-CoV-2
by
impeding
endocytic
release
virus.
enhances
early
endosome
recruitment
STX6.
STX6
appears
hinder
maturation
viral
particles-laden
endosomes
into
late
endosomes,
from
which
could
escape.
Instead,
it
promotes
trafficking
toward
autophagy-lysosomal
degradation
pathway.
exhibits
broad-spectrum
effect
against
various
variants
several
other
viruses
enter
via
endocytosis.
We
report
first
time
function
restrictive
in
infection.
IMPORTANCE
Virus
step
life
cycle,
exploitation
endo-lysosome
pathway
has
been
well
documented.
Meanwhile,
intrinsic
defense
present
within
cells
interferes
with
entry.
host
restriction
facilitating
Notably,
antiviral
activity
diverse
employing
endocytosis
Язык: Английский